VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,612 | -30.2% | 15,296 | -21.9% | 0.05% | -24.2% |
| Q2 2023 | $589,526 | -85.5% | 19,579 | -84.4% | 0.07% | -85.6% |
| Q1 2023 | $4,056,492 | -16.6% | 125,394 | -26.1% | 0.46% | -16.3% |
| Q4 2022 | $4,862,304 | -99.9% | 169,655 | -3.2% | 0.55% | +12.3% |
| Q3 2022 | $4,228,577,000 | +5.0% | 175,314 | +19.2% | 0.49% | +13.3% |
| Q2 2022 | $4,026,976,000 | +60657.0% | 147,077 | -14.9% | 0.43% | -27.6% |
| Q1 2022 | $6,628,000 | +171.1% | 172,819 | +126.4% | 0.59% | +231.8% |
| Q4 2021 | $2,445,000 | -18.4% | 76,319 | -24.9% | 0.18% | -21.8% |
| Q3 2021 | $2,995,000 | +108.0% | 101,625 | +139.9% | 0.23% | +114.0% |
| Q2 2021 | $1,440,000 | +184.0% | 42,370 | +171.5% | 0.11% | +174.4% |
| Q1 2021 | $507,000 | – | 15,607 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |